Skip to main content
Edward P. Browne, PhD

September 13, 2018

UNC Cure Center and Cell Microsystems Receive NIH Contract for Single Cell HIV Diagnostic Assay

The University of North Carolina at Chapel Hill HIV Cure Center and Cell Microsystems, a provider of innovative tools and scalable solutions for the sorting and isolation of single cells, announced they have received an approximately $283,000, 12-month Phase I Small Business Innovation and Research (SBIR) contract from the National Institutes of Health (NIH) to develop an automated platform to quantify the latent HIV reservoir.

Dr. Sylvia Becker-Dreps

June 14, 2018

UNC Study: Tdap Vaccine Given During Pregnancy Reduces Occurrence of Infant Pertussis

A study led by UNC’s Sylvia Becker-Dreps, MD, MPH, reviewed more than 675,000 pregnancies in the U.S. to determine if the Tdap vaccine given to a mother will reduce the chances of her child developing pertussis during the first 18 months of life. The results show a decrease in overall cases of pertussis, and most notably, in pertussis hospitalization in infants whose mothers were immunized during pregnancy.